Get the Stockscreener App
19.94
1.27%
0.25
Ceribell Inc stock is traded at $19.94, with a volume of 349.07K.
It is up +1.27% in the last 24 hours and down -9.12% over the past month.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
See More
Previous Close:
$19.69
Open:
$19.73
24h Volume:
349.07K
Relative Volume:
0.80
Market Cap:
$739.69M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-3.06%
1M Performance:
-9.12%
6M Performance:
+63.71%
1Y Performance:
-9.24%
1-Day Range:
$19.60
$20.04
1-Week Range:
$19.49
$20.71
52-Week Range:
$10.01
$26.04
Ceribell Inc Stock (CBLL) Company Profile
Name
Ceribell Inc
Sector
Industry
Phone
(800) 436-0826
Address
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
19.94 | 730.41M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | Raymond James | Strong Buy |
| Jun-24-25 | Initiated | BTIG Research | Buy |
| Apr-04-25 | Initiated | Ladenburg Thalmann | Buy |
| Nov-05-24 | Initiated | BofA Securities | Buy |
| Nov-05-24 | Initiated | Canaccord Genuity | Buy |
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Initiated | William Blair | Outperform |
View All
Ceribell Inc Stock (CBLL) Latest News
Ceribell to Participate in Upcoming March Investor Conferences - The Manila Times
Ceribell CEO and CFO to speak at two March investor conferences - Stock Titan
CenterBook Partners LP Increases Stake in CeriBell, Inc. $CBLL - MarketBeat
CeriBell, Inc. (CBLL) Stock Analysis: A 41% Upside Potential In Revolutionary Medical Devices - DirectorsTalk Interviews
What drives CeriBell Inc.’s stock price2025 Big Picture & Capital Protection Trade Alerts - mfd.ru
Market Overview: How sensitive is CeriBell Inc to inflation2025 Price Targets & Weekly Return Optimization Alerts - baoquankhu1.vn
FMR LLC Reduces Stake in CeriBell Inc: A Strategic Portfolio Adj - GuruFocus
Is CeriBell Inc. forming a breakout pattern2025 Geopolitical Influence & Entry and Exit Point Strategies - mfd.ru
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - The Manila Times
Ceribell Inc introduces new neonatal EEG at NEO Pediatrix event - Traders Union
Ceribell, Inc. shows power of POCEEG in seizure detection - Traders Union
Ceribell CEO Chao Xingjuan sells $786k in shares - Investing.com
Ceribell CEO Chao Xingjuan sells $786k in shares By Investing.com - Investing.com South Africa
CeriBell (NASDAQ:CBLL) VP David Foehr Sells 5,556 Shares - MarketBeat
CeriBell, Inc. (NASDAQ:CBLL) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Is CeriBell (NASDAQ:CBLL) Using Debt In A Risky Way? - 富途牛牛
New medical partner - Northwest Indiana Business Magazine
Is CeriBell Inc. a top pick in the sectorJuly 2025 Update & Accurate Trade Setup Notifications - mfd.ru
What are the future prospects of CeriBell IncPortfolio Update Summary & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
What is CeriBell Incs 5 year growth outlook2025 Dividend Review & Trade Opportunity Analysis Reports - baoquankhu1.vn
What is CeriBell Inc. s revenue forecastJuly 2025 Breakouts & Weekly Return Optimization Alerts - mfd.ru
Ceribell: Strong Clinical Integration and AI-Driven Differentiation Support Buy Rating and High-Growth Outlook - TipRanks
BTIG Reiterates Buy Rating for CeriBell (CBLL) with $30 Price Ta - GuruFocus
Forecasting The Future: 5 Analyst Projections For CeriBell - Benzinga
Income Plays: Is CeriBell Inc a top pick in the sectorWeekly Loss Report & Community Trade Idea Sharing Platform - baoquankhu1.vn
Fed Meeting: What are the risks of holding CeriBell Inc2025 Top Gainers & Expert Curated Trade Ideas - baoquankhu1.vn
What’s the profit margin of CeriBell Inc.Analyst Upgrade & Safe Entry Trade Reports - mfd.ru
CeriBell, Inc. $CBLL Shares Acquired by Emerald Mutual Fund Advisers Trust - MarketBeat
Ceribell director resigns to pursue other professional ventures - MSN
CeriBell, Inc. (CBLL) Stock Analysis: A 24% Potential Upside Beckons in the Dynamic Medical Device Sector - DirectorsTalk Interviews
Targets Report: Is Bolt Projects Holdings Inc stock a buy or sellPortfolio Return Summary & Entry and Exit Point Strategies - baoquankhu1.vn
Ceribell director Parvizi sells $573k in shares By Investing.com - Investing.com South Africa
Josef Parvizi Sells 25,000 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Ceribell director Parvizi sells $573k in shares - Investing.com
CeriBell a new buy at BTIG on growth in EEG monitoring system - MSN
FDA clearances: Siemens Healthineers, Medtronic, CeriBell - Modern Healthcare
Risk Hedge: Does CeriBell Inc stock reflect fundamentalsJuly 2025 Levels & Daily Chart Pattern Signal Reports - baoquankhu1.vn
CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion - Yahoo Finance
Growth Value: Does CeriBell Inc have consistent dividend growthAnalyst Downgrade & Real-Time Market Trend Scan - baoquankhu1.vn
Protara, Ceribell rise on FDA breakthrough designations - MSN
CBLL: FDA-cleared AI neuromonitoring expands to pediatrics and delirium, driving growth and efficiency - TradingView
CBLL: 2026 growth will accelerate with new FDA clearances, VA expansion, and pediatric launches - TradingView — Track All Markets
Ceribell sues Natus Medical for patent infringement - MSN
CeriBell, Inc. (NASDAQ:CBLL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Ceribell shares advance after FDA grants breakthrough device status - MSN
CeriBell, Inc.'s (NASDAQ:CBLL) Shares May Have Run Too Fast Too Soon - simplywall.st
CeriBell, Inc. (CBLL) Stock Analysis: Healthcare Innovator With A 21.99% Upside Potential - DirectorsTalk Interviews
Is CeriBell Inc. stock a buy on dips2025 Top Decliners & Long-Term Safe Return Strategies - Улправда
Is CeriBell Inc. stock attractive for retirement portfoliosOptions Play & AI Driven Price Predictions - ulpravda.ru
Will CeriBell Inc. stock rally after Fed decisions2025 Key Highlights & Reliable Intraday Trade Plans - ulpravda.ru
Aug Technicals: Why CeriBell Inc. stock could outperform in 2025Portfolio Risk Summary & High Return Trade Opportunity Guides - ulpravda.ru
Ceribell Inc Stock (CBLL) Financials Data
There is no financial data for Ceribell Inc (CBLL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):